• About
  • Contact
  • Support Funtrafoo
  • Work With Us
No Result
View All Result
  • Home
  • FOOD
  • TRAVEL
  • HEALTH
  • TECHNOLOGY
  • LIFESTYLE
  • ENTERTAINMENT
  • EVENTS
  • FEEDS
  • WEB STORIES
  • Home
  • FOOD
  • TRAVEL
  • HEALTH
  • TECHNOLOGY
  • LIFESTYLE
  • ENTERTAINMENT
  • EVENTS
  • FEEDS
  • WEB STORIES
No Result
View All Result
No Result
View All Result
Home Daily Feeds

Glenmark Pharmaceuticals receives ANDA approval for Lacosamide Tablets USP, 50 mg, 100 mg, 150 mg and 200 mg

by PR Newswire
March 21, 2022
Reading Time: 3 mins read
0 0
0
ADVERTISEMENT
Share on FacebookShare on Twitter

Also Read

Innodisk Showcases Innovative Edge AI Computing Capabilities at Computex 2022

Innodisk Showcases Innovative Edge AI Computing Capabilities at Computex 2022

4 hours ago
0
Lyca Mobile to Deploy Flytxt CVM Accelerator Solution in Europe and US after Successful Pilot Program

Lyca Mobile to Deploy Flytxt CVM Accelerator Solution in Europe and US after Successful Pilot Program

4 hours ago
1

MUMBAI, India, March 21, 2022 /PRNewswire/ — Glenmark Pharmaceuticals Inc., USA (Glenmark) has received final approval by the United States Food & Drug Administration (U.S. FDA) for its Lacosamide Tablets1 USP, 50 mg, 100 mg, 150 mg and 200 mg, the generic version of Vimpat®2 Tablets, 50 mg, 100 mg, 150 mg and 200 mg of UCB, Inc. The company plans to launch the product immediately.

Glenmark Logo

Commenting on the development, Robert Crockart, Chief Commercial Officer, Glenmark Pharmaceuticals Ltd, said, “The FDA approval for generic Lacosamide Tablets USP reiterates our ongoing commitment to make treatment options more accessible for patients. We look forward to quickly launching this product in the U.S. market.” 

According to IQVIA™ sales data for the 12 month period ending January 2022, the Vimpat® Tablets, 50 mg, 100 mg, 150 mg and 200 mg market3 achieved annual sales of approximately $1.7 billion*.

Glenmark’s current portfolio consists of 174 products authorized for distribution in the U.S. marketplace and 45 ANDA’s pending approval with the U.S. FDA. In addition to these internal filings, Glenmark continues to identify and explore external development partnerships to supplement and accelerate the growth of its existing pipeline and portfolio.

About Glenmark Pharmaceuticals Ltd.

Glenmark Pharmaceuticals Ltd. (Glenmark) is a global innovation-driven pharmaceutical company with presence across Specialty, Generics and OTC businesses. Globally, Glenmark focuses on the following key therapy areas: respiratory, dermatology and oncology. The company has 10 world-class manufacturing facilities spread across 4 continents and operations in over 80 countries. It was ranked among the world’s top 50 Generics and Biosimilars companies (Top 50 Company Rankings, 2020, from Informa’s Generics Bulletin). The company has been listed on the Dow Jones Sustainability Index (DJSI), under the category of emerging markets for the fourth consecutive year in a row, most recently in 2021. DJSI is one of the world’s most respected and widely accepted sustainability benchmarks globally with only the top ranked companies in terms of Corporate Sustainability within each industry are featured in the index. www.glenmarkpharma.com

References:

1Glenmark’s Lacosamide Tablets are only approved for their FDA-approved indication.

2All brand names and trademarks are the property of their respective owners.

3Market includes brand and all available therapeutic equivalents.

*IQVIA™ National Sales Perspectives: Retail & Non-Retail, January 2022

Logo: https://mma.prnewswire.com/media/451507/PRNE_Glenmark_Logo.jpg

(This story is auto-generated from PR Newswire)

Tags: PR NewswirePress Releases
ShareTweetSendShare

Related Posts

Innodisk Showcases Innovative Edge AI Computing Capabilities at Computex 2022

Innodisk Showcases Innovative Edge AI Computing Capabilities at Computex 2022

May 26, 2022
0
Lyca Mobile to Deploy Flytxt CVM Accelerator Solution in Europe and US after Successful Pilot Program

Lyca Mobile to Deploy Flytxt CVM Accelerator Solution in Europe and US after Successful Pilot Program

May 26, 2022
1
Global Sales and Marketing agency BNZSA has launched a Decision Science practice and hires industry expert Angela Beresford to head it up

Global Sales and Marketing agency BNZSA has launched a Decision Science practice and hires industry expert Angela Beresford to head it up

May 26, 2022
0
IPL 2022: The Road So Far + Special Surprise From 10CRIC

IPL 2022: The Road So Far + Special Surprise From 10CRIC

May 26, 2022
1
No Result
View All Result
  • Coronavirus Vaccine Prices In India and Other Countries

    Coronavirus Vaccine Prices In India and Other Countries. Is Covid Vaccine Free?

    21 shares
    Share 21 Tweet 0
  • Padma Vibhushan, Padma Bhushan, Padma Shri: Full List Of Padma Award Winners 2021

    15 shares
    Share 15 Tweet 0
  • Importance And Benefits Of Vitamin D Rich Food

    1 shares
    Share 1 Tweet 0
  • Yoga Beginner’s Guide – Tips Before Attending The First Yoga Class

    1 shares
    Share 1 Tweet 0
  • Parliament of India: नया देश नया भवन

    0 shares
    Share 0 Tweet 0

Recent Posts

  • Steps To Download Covid-19 Vaccine Certificate Using Whatsapp
  • Celebrate International Cat Day (World Cat Day) On 8 August
  • Meet Neeraj Chopra Who Won 1st Gold Medal For India In Tokyo Olympics 2021
  • Robin Hood Army New Initiative #Mission28States To Help Vaccinate Underprivileged, Serve 5 Mn Meals
  • Top 10 most livable cities in the world
  • Home
  • Contact Us
  • About Us
  • Support Funtrafoo
  • Authors
FUN * TRAVEL * FOOD

© 2021 www.funtrafoo.com.

No Result
View All Result
  • Home
  • FOOD
  • TRAVEL
  • HEALTH
  • TECHNOLOGY
  • LIFESTYLE
  • ENTERTAINMENT
  • EVENTS
  • FEEDS
  • WEB STORIES

© 2021 www.funtrafoo.com.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In